source name	characteristics[organism]	characteristics[organism part]	characteristics[age]	characteristics[developmental stage]	characteristics[cell line]	characteristics[cell type]	characteristics[sex]	characteristics[disease]	characteristics[mass]	Charateristics[spiked compound]	characteristics[biological replicate]	Material Type	assay name	technology type	comment[data file]	comment[file uri]	comment[technical replicate]	comment[fraction identifier]	comment[label]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[cleavage agent details]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	Factor Value[disease]	Factor Value[spiked compound]
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 1	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr01.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	1	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 1	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr01.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	1	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 1	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr01.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	1	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 1	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr01.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	1	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 1	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr01.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	1	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 1	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr01.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	1	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 1	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr01.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	1	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 1	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr01.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	1	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 1	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr01.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	1	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 1	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr01.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	1	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 2	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	2	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 2	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	2	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 2	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	2	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 2	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	2	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 2	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	2	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 2	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	2	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 2	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	2	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 2	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	2	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 2	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	2	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 2	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	2	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 3	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	3	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 3	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	3	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 3	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	3	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 3	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	3	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 3	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	3	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 3	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	3	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 3	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	3	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 3	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	3	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 3	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	3	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 3	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	3	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 4	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	4	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 4	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	4	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 4	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	4	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 4	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	4	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 4	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	4	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 4	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	4	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 4	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	4	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 4	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	4	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 4	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	4	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 4	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	4	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 5	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	5	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 5	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	5	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 5	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	5	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 5	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	5	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 5	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	5	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 5	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	5	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 5	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	5	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 5	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	5	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 5	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	5	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 5	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	5	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 6	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	6	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 6	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	6	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 6	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	6	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 6	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	6	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 6	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	6	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 6	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	6	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 6	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	6	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 6	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	6	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 6	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	6	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 6	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	6	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 7	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	7	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 7	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	7	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 7	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	7	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 7	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	7	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 7	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	7	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 7	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	7	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 7	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	7	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 7	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	7	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 7	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	7	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 7	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	7	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 8	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	8	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 8	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	8	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 8	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	8	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 8	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	8	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 8	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	8	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 8	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	8	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 8	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	8	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 8	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	8	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 8	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	8	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 8	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	8	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 9	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	9	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 9	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	9	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 9	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	9	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 9	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	9	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 9	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	9	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 9	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	9	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 9	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	9	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 9	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	9	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 9	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	9	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 9	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	9	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 10	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	10	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 10	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	10	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 10	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	10	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 10	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	10	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 10	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	10	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 10	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	10	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 10	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	10	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 10	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	10	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 10	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	10	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 10	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	10	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 11	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	11	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 11	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	11	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 11	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	11	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 11	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	11	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 11	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	11	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 11	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	11	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 11	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	11	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 11	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	11	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 11	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	11	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 11	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	11	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 12	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	12	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 12	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	12	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 12	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	12	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 12	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	12	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 12	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	12	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 12	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	12	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 12	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	12	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 12	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	12	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 12	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	12	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 12	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	12	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 13	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	13	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 13	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	13	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 13	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	13	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 13	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	13	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 13	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	13	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 13	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	13	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 13	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	13	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 13	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	13	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 13	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	13	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 13	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	13	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 14	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	14	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 14	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	14	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 14	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	14	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 14	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	14	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 14	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	14	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 14	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	14	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 14	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	14	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 14	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	14	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 14	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	14	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 14	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	14	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 15	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	15	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 15	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	15	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 15	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	15	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 15	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	15	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 15	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	15	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 15	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	15	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 15	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	15	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 15	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	15	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 15	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	15	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 15	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	15	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 16	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	16	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 16	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	16	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 16	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	16	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 16	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	16	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 16	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	16	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 16	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	16	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 16	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	16	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 16	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	16	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 16	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	16	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 16	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	16	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 17	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	17	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 17	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	17	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 17	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	17	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 17	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	17	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 17	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	17	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 17	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	17	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 17	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	17	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 17	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	17	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 17	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	17	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 17	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	17	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 18	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	18	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 18	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	18	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 18	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	18	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 18	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	18	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 18	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	18	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 18	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	18	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 18	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	18	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 18	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	18	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 18	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	18	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 18	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	18	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 19	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	19	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 19	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	19	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 19	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	19	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 19	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	19	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 19	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	19	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 19	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	19	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 19	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	19	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 19	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	19	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 19	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	19	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 19	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	19	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 20	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	20	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 20	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	20	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 20	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	20	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 20	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	20	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 20	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	20	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 20	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	20	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 20	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	20	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 20	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	20	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 20	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	20	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 20	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	20	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 21	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	21	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 21	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	21	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 21	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	21	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 21	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	21	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 21	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	21	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 21	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	21	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 21	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	21	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 21	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	21	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 21	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	21	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 21	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	21	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 22	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	22	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 22	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	22	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 22	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	22	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 22	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	22	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 22	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	22	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 22	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	22	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 22	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	22	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 22	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	22	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 22	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	22	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 22	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	22	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 23	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	23	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 23	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	23	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 23	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	23	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 23	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	23	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 23	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	23	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 23	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	23	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 23	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	23	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 23	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	23	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 23	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	23	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 23	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	23	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 24	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	24	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 24	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	24	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 24	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	24	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 24	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	24	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 24	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	24	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 24	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	24	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 24	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	24	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 24	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	24	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 24	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	24	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 24	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	24	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 25	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	25	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 25	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	25	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 25	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	25	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 25	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	25	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 25	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	25	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 25	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	25	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 25	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	25	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 25	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	25	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 25	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	25	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 25	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	25	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 26	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	26	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 26	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	26	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 26	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	26	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 26	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	26	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 26	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	26	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 26	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	26	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 26	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	26	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 26	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	26	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 26	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	26	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 26	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	26	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 27	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	27	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 27	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	27	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 27	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	27	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 27	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	27	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 27	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	27	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 27	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	27	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 27	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	27	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 27	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	27	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 27	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	27	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 27	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	27	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 28	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	28	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 28	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	28	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 28	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	28	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 28	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	28	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 28	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	28	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 28	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	28	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 28	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	28	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 28	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	28	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 28	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	28	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 28	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	28	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 29	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	29	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 29	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	29	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 29	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	29	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 29	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	29	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 29	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	29	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 29	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	29	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 29	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	29	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 29	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	29	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 29	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	29	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 29	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	29	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 30	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	30	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 30	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	30	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 30	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	30	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 30	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	30	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 30	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	30	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 30	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	30	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 30	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	30	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 30	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	30	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 30	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	30	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 30	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	30	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 31	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	31	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 31	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	31	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 31	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	31	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 31	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	31	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 31	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	31	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 31	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	31	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 31	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	31	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 31	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	31	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 31	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	31	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 31	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	31	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 32	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	32	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 32	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	32	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 32	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	32	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 32	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	32	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 32	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	32	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 32	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	32	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 32	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	32	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 32	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	32	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 32	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	32	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 32	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	32	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 33	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	33	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 33	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	33	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 33	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	33	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 33	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	33	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 33	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	33	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 33	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	33	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 33	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	33	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 33	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	33	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 33	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	33	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 33	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	33	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 34	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	34	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 34	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	34	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 34	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	34	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 34	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	34	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 34	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	34	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 34	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	34	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 34	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	34	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 34	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	34	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 34	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	34	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 34	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	34	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 35	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	35	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 35	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	35	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 35	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	35	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 35	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	35	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 35	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	35	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 35	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	35	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 35	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	35	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 35	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	35	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 35	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	35	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 35	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	35	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 36	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	36	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 36	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	36	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 36	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	36	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 36	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	36	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 36	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	36	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 36	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	36	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 36	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	36	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 36	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	36	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 36	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	36	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 36	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	36	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 37	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr64.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	37	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 37	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr64.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	37	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 37	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr64.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	37	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 37	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr64.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	37	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 37	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr64.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	37	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 37	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr64.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	37	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 37	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr64.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	37	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 37	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr64.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	37	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 37	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr64.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	37	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 37	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr64.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	37	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 38	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr65.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	38	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 38	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr65.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	38	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 38	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr65.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	38	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 38	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr65.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	38	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 38	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr65.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	38	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 38	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr65.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	38	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 38	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr65.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	38	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 38	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr65.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	38	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 38	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr65.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	38	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 38	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr65.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	38	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 39	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr66.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	39	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 39	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr66.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	39	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 39	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr66.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	39	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 39	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr66.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	39	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 39	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr66.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	39	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 39	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr66.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	39	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 39	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr66.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	39	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 39	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr66.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	39	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 39	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr66.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	39	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 39	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr66.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	39	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 40	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr71.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	40	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 40	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr71.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	40	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 40	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr71.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	40	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 40	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr71.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	40	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 40	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr71.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	40	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 40	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr71.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	40	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 40	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr71.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	40	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 40	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr71.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	40	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 40	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr71.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	40	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 40	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr71.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	40	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 1	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	1	cell	run 41	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr72.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	41	TMT126	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 2	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	2	cell	run 41	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr72.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	41	TMT127N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 3	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house	3	cell	run 41	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr72.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	41	TMT127C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=7.5 ug;CV=in-house
Sample 4	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	1	cell	run 41	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr72.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	41	TMT128N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 5	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	2	cell	run 41	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr72.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	41	TMT128C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 6	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	3	cell	run 41	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr72.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	41	TMT129N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 7	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house	4	cell	run 41	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr72.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	41	TMT129C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=15 ug;CV=in-house
Sample 8	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	1	cell	run 41	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr72.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	41	TMT130N	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 9	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	2	cell	run 41	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr72.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	41	TMT130C	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
Sample 10	Homo sapiens	breast	69Y	elderly	MCF-7	epithelial cell	female	breast adenocarcinoma	70 ug	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house	3	cell	run 41	proteomic profiling by mass spectrometry	GMHJYZ_DeqMSvalidation_300ug_TMT10_IPG3-10_fr72.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007985/p01.raw	1	41	TMT131	NT=Q Exactive HF;AC=MS:1002523	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed	NT=TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	30%-40% NCE	10 ppm	0.11 Da	breast adenocarcinoma	SP=Escherichia coli K-12;CT=Mixture;QY=45 ug;CV=in-house
